Page last updated: 2024-10-21

acebutolol and Atrioventricular Nodal Re-Entrant Tachycardia

acebutolol has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 2 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steriotis, AK1
Nava, A1
Rampazzo, A1
Basso, C1
Thiene, G1
Daliento, L1
Folino, AF1
Rigato, I1
Mazzotti, E1
Beffagna, G1
Carturan, E1
Corrado, D1
Bauce, B1
Leclercq, JF1
Leenhardt, A1
Coumel, P1
Slama, R1

Other Studies

2 other studies available for acebutolol and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations.
    The American journal of cardiology, 2012, Apr-01, Volume: 109, Issue:7

    Topics: Acebutolol; Adolescent; Adult; Anti-Arrhythmia Agents; Cohort Studies; Death, Sudden, Cardiac; Echoc

2012
Efficacy of beta-blocking agents in reducing the number of shocks in patients implanted with first-generation automatic defibrillators.
    European heart journal, 1992, Volume: 13, Issue:9

    Topics: Acebutolol; Adolescent; Adult; Aged; Amiodarone; Combined Modality Therapy; Dose-Response Relationsh

1992